ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

The role of PD-1/PD-L1 and application of immune-checkpoint inhibitors in human cancers

Tang, Qing; Chen, Yun; Li, Xiaojuan; Long, Shunqin; Shi, Yao; Yu, Yaya; Wu, Wanyin*; Han, Ling*; Wang, Sumei*广东省人民医院; 广州医学院; 广州中医药大学
Frontiers in Immunology2022-9-13DOI: 10.3389/fimmu.2022.964442
57被引10阅读
引用收藏
分享

摘要

Programmed cell death protein-1 (PD-1) is a checkpoint receptor expressed on the surface of various immune cells. PD-L1, the natural receptor for PD-1, is mainly expressed in tumor cells. Studies have indicated that PD-1 and PD-L1 are closely associated with the progression of human cancers and are promising biomarkers for cancer therapy. Moreover, the interaction of PD-1 and PD-L1 is one of the important mechanism by which human tumors generate immune escape. This article provides a review on the role of PD-L1/PD-1, mechanisms of immune response and resistance, as well as immune-related adverse events in the treatment of anti-PD-1/PD-L1 immunotherapy in human cancers. Moreover, we summarized a large number of clinical trials to successfully reveal that PD-1/PD-L1 Immune-checkpoint inhibitors have manifested promising therapeutic effects, which have been evaluated from different perspectives, including overall survival, objective effective rate and medium progression-free survival. Finally, we pointed out the current problems faced by PD-1/PD-L1 Immune-checkpoint inhibitors and its future prospects. Although PD-1/PD-L1 immune checkpoint inhibitors have been widely used in the treatment of human cancers, tough challenges still remain. Combination therapy and predictive models based on integrated biomarker determination theory may be the future directions for the application of PD-1/PD-L1 Immune-checkpoint inhibitors in treating human cancers.

学科与关键词

关键词
PD-1PD-L1immunecheckpoint inhibitorclinical applicationbiomarkerhuman cancers
相关
加载中…
  • Biomarkers for immune checkpoint therapy targeting programmed death 1 and programmed death ligand 1
    Fan, Jingjing; Shen, Xiangfeng; Wang, Yishu; Zhou, Hong-Lan; Liu, Guolong; Li, Yu-Lin; Xu, Zhi-Xiang*Biomedicine and Pharmacotherapy, 2020, 130: 110621.被引 8
  • Role of the tumor microenvironment in PD-L1/PD-1-mediated tumor immune escape.
    Jiang, Xianjie; Wang, Jie; Deng, Xiangying; Xiong, Fang; Ge, Junshang; Xiang, Bo; Wu, Xu; Ma, Jian; Zhou, Ming; Li, Xiaoling; Li, Yong; Li, Guiyuan; Xiong, Wei; Guo, Can*; Zeng, Zhaoyang*Molecular Cancer, 2019, 18(1): 10.
  • New developments in the mechanism and application of immune checkpoint inhibitors in cancer therapy (Review)
    Wang, Yanjun; Yang, Shuo; Wan, Li; Ling, Wei; Chen, Hao*; Wang, Jinghua*International Journal of Oncology, 2023, 63(1): 86.被引 3
查看全部 →

发表信息

论文状态
公开发表
期刊
Frontiers in Immunology
发表日期
2022-09-13
卷期
第 13 卷
页码
964442
DOI
10.3389/fimmu.2022.964442
语言
ENGLISH
期刊等级
2区
成果收录
SCIE
资助标注
Natural Science Foundation of China [81974543, 81903991, 81703551, 81871863]; Natural Science Foundation of Guangdong Province [2019A1515011362, 2021A1515410007, 2021A1515220023]; Guangzhou science and technology plan project [202002030155, 202102010160]; Scientific Research Project in Universities of Guangdong Provincial Department of Education [2020KTSCX029]; Chinese medicine science and technology research project of Guangdong Provincial Hospital of Chinese Medicine [YN2019MJ09, YN2019QJ06]; Guangdong Provincial Key Laboratory of Clinical Research on Traditional Chinese Medicine Syndrome [ZH2020KF03]; Key project of State Key Laboratory of dampness syndrome of Chinese medicine [SZ2021ZZ38, SZ2021ZZ29]; Science and Technology Planning Project of Guangdong Province [2017B030314166]; Research Fund for Bajian Talents of Guangdong Provincial Hospital of Chinese Medicine [BJ2022KY13]

作者

  • T

    Tang, Qing (第一作者)

    2 · guangdong prov hosp · guangzhou univ chinese med

  • C

    Chen, Yun

    2 · guangzhou med univ

查看全部 9 位作者收起作者
  • L

    Li, Xiaojuan

    shanghai univ tradit chinese med

  • L

    Long, Shunqin

    2 · guangdong prov hosp · guangzhou univ chinese med

  • S

    Shi, Yao

    2 · guangdong prov hosp · guangzhou univ chinese med

  • Y

    Yu, Yaya

    2 · guangdong prov hosp · guangzhou univ chinese med

  • W

    Wu, Wanyin (通讯)

    2 · guangdong prov hosp · guangzhou univ chinese med

  • H

    Han, Ling (通讯)

    2 · guangdong prov hosp · guangzhou univ chinese med

  • W

    Wang, Sumei (通讯)

    2 · guangdong prov hosp · guangzhou univ chinese med

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417